Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (290) 290
Publication (82) 82
Book Chapter (7) 7
Patent (4) 4
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
index medicus (130) 130
female (120) 120
oncology (101) 101
middle aged (85) 85
risk factors (70) 70
article (67) 67
aged (66) 66
breast cancer (61) 61
cancer (59) 59
medical and health sciences (53) 53
medicin och hälsovetenskap (53) 53
adult (51) 51
risk (49) 49
male (43) 43
clinical medicine (41) 41
klinisk medicin (41) 41
cancer and oncology (38) 38
cancer och onkologi (38) 38
research (37) 37
health aspects (34) 34
case-control studies (33) 33
public, environmental & occupational health (33) 33
cohort studies (32) 32
prospective studies (30) 30
epidemiology (29) 29
mortality (24) 24
health risk assessment (23) 23
polymorphism, single nucleotide (22) 22
incidence (21) 21
aged, 80 and over (20) 20
women (20) 20
breast-cancer (19) 19
analysis (18) 18
united states - epidemiology (18) 18
breast neoplasms - epidemiology (17) 17
genetic aspects (17) 17
genetic predisposition to disease (17) 17
health (17) 17
obstetrics & gynecology (17) 17
postmenopausal women (17) 17
young adult (17) 17
association (16) 16
cohort (16) 16
obesity (16) 16
studies (16) 16
abridged index medicus (15) 15
biomarkers (15) 15
diagnosis (15) 15
health risks (15) 15
metaanalysis (15) 15
oncology, experimental (15) 15
pancreatic cancer (15) 15
prognosis (15) 15
risk assessment (15) 15
breast neoplasms - pathology (14) 14
genotype (14) 14
survival (14) 14
tumors (14) 14
body mass index (13) 13
breast (13) 13
breast neoplasms - mortality (13) 13
disease (13) 13
genome-wide association study (13) 13
odds ratio (13) 13
smoking (13) 13
breast neoplasms - prevention & control (12) 12
follow-up studies (12) 12
genes (12) 12
genome-wide association (12) 12
journal article (12) 12
medicine & public health (12) 12
medicine, general & internal (12) 12
mutation (12) 12
neoplasm staging (12) 12
ovarian cancer (12) 12
pancreatic neoplasms - genetics (12) 12
population (12) 12
public health (12) 12
womens health (12) 12
breast neoplasms - genetics (11) 11
care and treatment (11) 11
lung cancer (11) 11
regression analysis (11) 11
age factors (10) 10
c-reactive protein (10) 10
inflammation (10) 10
mutations (10) 10
surveys and questionnaires (10) 10
united states (10) 10
age (9) 9
breast neoplasms - drug therapy (9) 9
cancer research (9) 9
colorectal cancer (9) 9
consortia (9) 9
development and progression (9) 9
expression (9) 9
genetics (9) 9
genomes (9) 9
logistic models (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Beta Blockers and Breast Cancer Mortality: A Population- Based Study
by Thomas I. Barron and Roisin M. Connolly and Linda Sharp and Kathleen Bennett and Kala Visvanathan
Journal of Clinical Oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 19, pp. 2635 - 2644
Purpose Preclinical studies have demonstrated that antagonism of beta(2)-adrenergic signaling inhibits several pathways necessary for breast tumor progression... 
INVASION | METASTASIS | CARCINOMA CELLS | ONCOLOGY | NEUROTRANSMITTERS | RISK | CHRONIC STRESS | PROGRESSION | MODULATION | ENDOTHELIAL GROWTH-FACTOR | DELAYED PRESENTATION | Signal Transduction | Humans | Middle Aged | Propranolol - therapeutic use | Probability | Breast Neoplasms - drug therapy | Disease Progression | Breast Neoplasms - prevention & control | Incidence | Adrenergic beta-Antagonists - pharmacology | Breast Neoplasms - complications | Regression Analysis | Neoplasm Metastasis | Atenolol - therapeutic use | Hypertension - complications | Breast Neoplasms - mortality | Female | Aged | Odds Ratio
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Optimizing vitamin D concentrations for breast cancer risk reduction
by Vered Stearns, Stearns and Kala Visvanathan, Visvanathan
Medicine (United States), ISSN 0025-7974, 05/2013, Volume 92, Issue 3, pp. 132 - 134
SUPPLEMENTATION | POPULATION | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | D INSUFFICIENCY | TASK-FORCE | Dose-Response Relationship, Drug | Female | Vitamin D - administration & dosage | Humans | Breast Neoplasms - prevention & control | Vitamin D - blood | Care and treatment | Usage | Vitamin D | Calcifediol | Breast cancer | Diagnosis | Alfacalcidol | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Statin use and breast cancer survival: A nationwide cohort study from Finland
by Murtola, Teemu J and Visvanathan, Kala and Artama, Miia and Vainio, Harri and Pukkala, Eero
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e110231
Recent studies have suggested that statins, an established drug group in the prevention of cardiovascular mortality, could delay or prevent breast cancer... 
MORTALITY | POPULATION | THERAPY | CHOLESTEROL | PATHWAY | MULTIDISCIPLINARY SCIENCES | RISK | RECURRENCE | SIMVASTATIN | ADHERENCE | P53 | Cancer patients | Analysis | Oncology, Experimental | Breast cancer | Research | Health aspects | Statins | Cancer | Mortality | Health risks | Risk | Hazards | Mammography | Medical diagnosis | Patients | Survival | Studies | Prescription drugs | Dependent variables | Breast | Diagnostic systems | Diagnosis | Cardiovascular diseases | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text BRCA1 and BRCA2 testing in medically underserved medicare beneficiaries with breast or ovarian cancer
by Gross, Amy L and Blot, William J and Visvanathan, Kala
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 08/2018, Volume 320, Issue 6, pp. 597 - 598
This study uses US community cohort data to assess BRCA1 and BRCA2 testing among medically underserved Medicare beneficiaries with breast cancer, ovarian... 
MEDICINE, GENERAL & INTERNAL | Medically Underserved Area | Medicare | Genetic Testing - statistics & numerical data | United States | Humans | Middle Aged | Insurance Coverage | Ovarian Neoplasms - genetics | Breast Neoplasms - genetics | Genes, BRCA2 | Germ-Line Mutation | Female | Aged | Genes, BRCA1 | Cohort Studies | BRCA2 protein | Health care | Ovarian carcinoma | BRCA1 protein | Government programs | Breast cancer | Ovarian cancer | Letter | Letters | Research Letter
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis
by Moore, Steven C and Patel, Alpa V and Matthews, Charles E and Berrington de Gonzalez, Amy and Park, Yikyung and Katki, Hormuzd A and Linet, Martha S and Weiderpass, Elisabete and Visvanathan, Kala and Helzlsouer, Kathy J and Thun, Michael and Gapstur, Susan M and Hartge, Patricia and Lee, I-Min
PLoS Medicine, ISSN 1549-1277, 11/2012, Volume 9, Issue 11, p. e1001335
Background: Leisure time physical activity reduces the risk of premature mortality, but the years of life expectancy gained at different levels remains... 
BREAST-CANCER | UNITED-STATES | ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASE MORTALITY | LOW-DOSE ASPIRIN | MEASUREMENT ERROR | REGRESSION-MODELS | PRIMARY PREVENTION | LIFE EXPECTANCY | WOMENS HEALTH | Body Mass Index | Leisure Activities | United States - epidemiology | Prospective Studies | Risk Assessment | Humans | Middle Aged | Mortality | Self Report | Male | Motor Activity | Young Adult | Life Expectancy | Obesity - epidemiology | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Metabolic Equivalent | Cohort Studies | Control | Exercise | Leisure | United States | Physiological aspects | Health aspects | Studies | Body mass index | Obesity | Physical fitness | Community medicine, Social medicine: 801 | Samfunnsmedisin, sosialmedisin: 801 | VDP | Helsefag: 800 | Health sciences: 800 | Medisinske Fag: 700 | Medical disciplines: 700
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline
by Kala Visvanathan and Patricia Hurley and Elissa Bantug and Powel Brown and Nananda F. Col and Jack Cuzick and Nancy E. Davidson and Andrea DeCensi and Carol Fabian and Leslie Ford and Judy Garber and Maria Katapodi and Barnett Kramer and Monica Morrow and Barbara Parker and Carolyn Runowicz and Victor G. Vogel III and James L. Wade and Scott M. Lippman
Journal of Clinical Oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2942 - 2962
Purpose To update the 2009 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. Methods A... 
CONTINUING OUTCOMES RELEVANT | TECHNOLOGY-ASSESSMENT | SURGICAL ADJUVANT BREAST | ONCOLOGY | CARDIOVASCULAR EVENTS | INCLUDING TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | BOWEL PROJECT | POSTMENOPAUSAL WOMEN | TAMOXIFEN PROPHYLAXIS | Meta-Analysis as Topic | Risk Assessment | Risk Reduction Behavior | Humans | Tamoxifen - therapeutic use | Adult | Female | Anticarcinogenic Agents - therapeutic use | Breast Neoplasms - prevention & control | Practice Guidelines as Topic | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study
by Narayan, Anand K and Visvanathan, Kala and Harvey, Susan C
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2016, Volume 158, Issue 3, pp. 583 - 589
Screening guidelines recommend that women with 20 % or greater lifetime risk of breast cancer undergo annual breast MRI screening to supplement mammography,... 
Screening | Medicine & Public Health | Magnetic resonance imaging | Oncology | Breast cancer | Mammography | High-risk women | MULTICENTER | CARCINOMA IN-SITU | ACCURACY | DENSITY | ACR | THERAPY | ULTRASOUND | ONCOLOGY | RECOMMENDATIONS | AGE | HISTORY | Multimodal Imaging | Humans | Sensitivity and Specificity | Magnetic Resonance Imaging - methods | Adult | Female | Retrospective Studies | Breast Neoplasms - diagnostic imaging | Mammography - methods | Breast Neoplasms - epidemiology | Image-Guided Biopsy | Incidence | Women | Oncology, Experimental | Diagnosis | Research | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma
by Shah, Ami A and Hummers, Laura K and Casciola‐Rosen, Livia and Visvanathan, Kala and Rosen, Antony and Wigley, Fredrick M
Arthritis & Rheumatology, ISSN 2326-5191, 04/2015, Volume 67, Issue 4, pp. 1053 - 1061
Objective We previously reported a contemporaneous onset of cancer and scleroderma in patients with anti–RNA polymerase III antibodies, and we identified a... 
BREAST-CANCER | ANTIBODIES | POPULATION | DERMATOMYOSITIS | POLYMYOSITIS | DISEASE | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | RNA-POLYMERASE-III | Scleroderma, Systemic - blood | Autoantibodies - blood | Humans | Middle Aged | Risk Factors | Male | Scleroderma, Systemic - immunology | RNA Polymerase III - immunology | Neoplasms - complications | Neoplasms - blood | Neoplasms - immunology | Scleroderma, Systemic - complications | Adult | Female | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
by Agyeman, Abena S and Agyeman, Abena S and Chaerkady, Raghothama and Chaerkady, Raghothama and Shaw, Patrick G and Shaw, Patrick G and Davidson, Nancy E and Davidson, Nancy E and Visvanathan, Kala and Visvanathan, Kala and Pandey, Akhilesh and Pandey, Akhilesh and Kensler, Thomas W and Kensler, Thomas W
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2012, Volume 132, Issue 1, pp. 175 - 187
Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a potent inhibitor of experimental mammary carcinogenesis and may be an effective,... 
Prevention | Biomarker discovery | Medicine & Public Health | Sulforaphane | Keap1/Nrf2 pathway | Oncology | SILAC | Microarray | Keap1/ Nrf2 pathway | CLINICAL-TRIAL | ANTIOXIDANT RESPONSE ELEMENTS | NRF2 | ONCOLOGY | AMINO-ACIDS | PROSTATE-CANCER CELLS | GENE-EXPRESSION | ISOTHIOCYANATE SULFORAPHANE | ALDOSE REDUCTASE | BROCCOLI SPROUTS | CACO-2 CELLS | Up-Regulation | Epithelial Cells - metabolism | Oligonucleotide Array Sequence Analysis | Epithelial Cells - drug effects | Humans | Transcriptome | Gene Expression Profiling | Intracellular Signaling Peptides and Proteins - metabolism | NAD(P)H Dehydrogenase (Quinone) - genetics | Gene Knockdown Techniques | Alcohol Oxidoreductases - genetics | RNA Interference | Thiocyanates - pharmacology | Female | Aldehyde Dehydrogenase - metabolism | Anticarcinogenic Agents - pharmacology | Intracellular Signaling Peptides and Proteins - genetics | Isothiocyanates | Kelch-Like ECH-Associated Protein 1 | Cell Line | Breast - cytology | Alcohol Oxidoreductases - metabolism | Aldehyde Dehydrogenase - genetics | NAD(P)H Dehydrogenase (Quinone) - metabolism | Proteome - metabolism | Proteins | Antioxidants | Xenobiotics | Toy industry | Estrogen | Index Medicus | sulforaphane | microarray | Keap1 | Nrf2 pathway | biomarker discovery | prevention
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Leisure time physical activity and mortality: A detailed pooled analysis of the dose-response relationship
by Arem, Hannah and Moore, Steven C and Patel, Alpa and Hartge, Patricia and Berrington De Gonzalez, Amy and Visvanathan, Kala and Campbell, Peter T and Freedman, Michal and Weiderpass, Elisabete and Adami, Hans Olov and Linet, Martha S and Lee, I.-Min and Matthews, Charles E
JAMA Internal Medicine, ISSN 2168-6106, 06/2015, Volume 175, Issue 6, pp. 959 - 967
IMPORTANCE The 2008 Physical Activity Guidelines for Americans recommended a minimum of 75 vigorous-intensity or 150 moderate-intensity minutes per week (7.5... 
ALL-CAUSE MORTALITY | VIGOROUS EXERCISE | BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE | CARDIOVASCULAR-DISEASE | COHORT | RANDOMIZED CONTROLLED-TRIAL | CORONARY-HEART-DISEASE | PRIMARY PREVENTION | WOMENS HEALTH | United States | Humans | Middle Aged | Mortality | Male | Young Adult | Exercise | Recreation | Aged, 80 and over | Adult | Female | Aged | Cohort Studies | Dose-response relationship (Biochemistry) | Analysis | Longevity | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer
by Igusa, Takeru and Hummers, Laura K and Visvanathan, Kala and Richardson, Carrie and Wigley, Fredrick M and Casciola-Rosen, Livia and Rosen, Antony and Shah, Ami A
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2018, Volume 77, Issue 8, pp. 1179 - 1187
ObjectivesRecent studies demonstrate autoantibodies are powerful tools to interrogate molecular events linking cancer and the development of autoimmunity in... 
epidemiology | autoantibodies | Systemic sclerosis | BREAST-CANCER | MALIGNANCY | METAANALYSIS | POPULATION-BASED COHORT | CLASSIFICATION | POLYMERASE-III ANTIBODIES | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | ASSOCIATION | ANTI-CENP-B | Lupus | Immunoglobulins | Phenotypes | Autoantibodies | Risk groups | Lung cancer | Rheumatology | Medical records | Arthritis | Breast cancer | Medical diagnosis | Epidemiology | Patients | DNA-directed RNA polymerase | Studies | Surveillance | Classification | Population | Rheumatism | Mutation | Scleroderma | Health risk assessment | malignancy | systemic sclerosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
by Wentzensen, Nicolas and Poole, Elizabeth M and Trabert, Britton and White, Emily and Arslan, Alan A and Patel, Alpa V and Setiawan, V. Wendy and Visvanathan, Kala and Weiderpass, Elisabete and Adami, Hans-Olov and Black, Amanda and Bernstein, Leslie and Brinton, Louise A and Buring, Julie and Butler, Lesley M and Chamosa, Saioa and Clendenen, Tess V and Dossus, Laure and Fortner, Renee and Gapstur, Susan M and Gaudet, Mia M and Gram, Inger T and Hartge, Patricia and Hoffman-Bolton, Judith and Idahl, Annika and Jones, Michael and Kaaks, Rudolf and Kirsh, Victoria and Koh, Woon-Puay and Lacey, James V., Jr and Lee, I-Min and Lundin, Eva and Merritt, Melissa A and Onland-Moret, N. Charlotte and Peters, Ulrike and Poynter, Jenny N and Rinaldi, Sabina and Robien, Kim and Rohan, Thomas and Sandler, Dale P and Schairer, Catherine and Schouten, Leo J and Sjoholm, Louise K and Sieri, Sabina and Swerdlow, Anthony and Tjonneland, Anna and Travis, Ruth and Trichopoulou, Antonia and van den Brandt, Piet A and Wilkens, Lynne and Wolk, Alicja and Yang, Hannah P and Zeleniuch-Jacquotte, Anne and Tworoger, Shelley S and Medicinska fakulteten and Institutionen för klinisk vetenskap and Obstetrik och gynekologi and Institutionen för medicinsk biovetenskap and Umeå universitet
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 24, pp. 2888 - 2898
Purpose An understanding of the etiologic heterogeneity of ovarian cancer is important for improving prevention, early detection, and therapeutic approaches.... 
PATHOGENESIS | MORTALITY | PROSTATE | WOMEN | LUNG | ASSOCIATIONS | ONCOLOGY | INFLAMMATION | POOLED ANALYSIS | GRADE | SMOKING | Adenocarcinoma, Clear Cell - epidemiology | Neoplasms, Glandular and Epithelial - pathology | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Neoplasms, Glandular and Epithelial - epidemiology | Risk Factors | Ovarian Neoplasms - pathology | Proportional Hazards Models | Europe - epidemiology | Cystadenocarcinoma, Serous - pathology | Adenocarcinoma, Mucinous - epidemiology | Ovarian Neoplasms - epidemiology | Asia - epidemiology | Carcinoma, Ovarian Epithelial | Adult | Female | Adenocarcinoma, Clear Cell - pathology | North America - epidemiology | Cystadenocarcinoma, Serous - epidemiology | Carcinoma, Endometrioid - epidemiology | Carcinoma, Endometrioid - pathology | Original Reports | Epid1 | Epid3 | Gync15 | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers
by Berrington de Gonzalez, Amy and Berg, Christine D and Visvanathan, Kala and Robson, Mark
Journal of the National Cancer Institute, ISSN 0027-8874, 2/2009, Volume 101, Issue 3, pp. 205 - 209
BRCA mutation carriers are recommended to start mammographic screening for breast cancer as early as age 25-30 years. We used an excess relative risk model... 
MORTALITY | WOMEN | X-RAYS | ONCOLOGY | MRI | IONIZING-RADIATION | PROGRAM | Age Factors | Risk Assessment | Humans | Neoplasms, Radiation-Induced - etiology | Risk Factors | Breast Neoplasms - etiology | Mammography - adverse effects | Models, Statistical | Mass Screening - methods | Breast Neoplasms - prevention & control | Breast Neoplasms - genetics | Mass Screening - adverse effects | Genes, BRCA2 | Adult | Female | Heterozygote | Breast Neoplasms - diagnostic imaging | Genes, BRCA1 | Mutation | Neoplasms, Radiation-Induced - epidemiology | Breast Neoplasms - epidemiology | Breast cancer | Prognosis | Diagnosis | Risk factors | Risk assessment | Radiation | Oncology | Mammography | Medical screening | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Adverse effects of early bilateral oophorectomy on body composition: Results from a nationally representative sample of United States women
by Karia, Pritesh S and Joshu, Corinne and Visvanathan, Kala
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 1568 - 1568
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Association between Class III Obesity (BMI of 40-59 kg/m 2 ) and Mortality: A Pooled Analysis of 20 Prospective Studies
by Kitahara, Cari M and Flint, Alan J and Berrington de Gonzalez, Amy and Bernstein, Leslie and Brotzman, Michelle and MacInnis, Robert J and Moore, Steven C and Robien, Kim and Rosenberg, Philip S and Singh, Pramil N and Weiderpass, Elisabete and Adami, Hans Olov and Anton-Culver, Hoda and Ballard-Barbash, Rachel and Buring, Julie E and Freedman, D. Michal and Fraser, Gary E and Beane Freeman, Laura E and Gapstur, Susan M and Gaziano, John Michael and Giles, Graham G and Håkansson, Niclas and Hoppin, Jane A and Hu, Frank B and Koenig, Karen and Linet, Martha S and Park, Yikyung and Patel, Alpa V and Purdue, Mark P and Schairer, Catherine and Sesso, Howard D and Visvanathan, Kala and White, Emily and Wolk, Alicja and Zeleniuch-Jacquotte, Anne and Hartge, Patricia
PLoS Medicine, ISSN 1549-1277, 2014, Volume 11, Issue 7, p. e1001673
Background: The prevalence of class III obesity (body mass index [BMI]>= 40 kg/m(2)) has increased dramatically in several countries and currently affects 6%... 
BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | DESIGN | PREDICTING MORTALITY | DISEASE | WEIGHT-LOSS | BODY-MASS INDEX | MORBID-OBESITY | PHYSICAL-ACTIVITY | ADIPOSITY | CARDIOVASCULAR RISK-FACTORS | Body Mass Index | United States - epidemiology | Prospective Studies | Life Expectancy | Humans | Risk Factors | Obesity - mortality | Sweden - epidemiology | Australia - epidemiology | Obesity | Complications and side effects | Body mass index | Care and treatment | Development and progression | Research | Heart diseases | Risk factors | Samfunnsmedisin, sosialmedisin: 801 | Community medicine, Social medicine: 801 | Epidemiology medical and dental statistics: 803 | Epidemiologi medisinsk og odontologisk statistikk: 803 | VDP | Helsefag: 800 | Health sciences: 800 | Medisinske Fag: 700 | Medical disciplines: 700 | Studies | Mortality | Men | Health risk assessment | Chronic illnesses
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights